Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.LIZ HUNT
Health Editor
The testing of British blood supplies is less stringent than in many other European countries, and at least 250 people each year contract potentially life-threatening viral infections as a result, a doctor is warning.
Dr Lesley Kay, a consultant haematologist in private practice, says donated blood should be routinely screened for the human T-cell leukaemia/ lymphoma virus (HTLV-1), and the hepatitis B "core antibody". The latter is a more sensitive test - indicating that a person has been infected with hepatitis B in the past - than that in present use which indicates active infection.
Blood authorities in France, Sweden, and the Netherlands, where the prevalence of HTLV-1 in the population is the same as Britain - about 1 in 20,000 - do screen for it, Dr Kay says. Portugal will introduce screening this year. In Japan, the US, and Canada, screening is mandatory. France, Germany, and several other European countries also screen blood for hepatitis B core antibodies.
In a letter published in tomorrow's issue of the British Medical Journal, Dr Kay says that around 200 people are infected with HTLV-1 annually, following blood transfusion, while there are around 50 cases of hepatitis B transmission.
"The blood supply in Britain is manifestly not as safe as it can be reasonably made," she writes.
A spokesman for the Department of Health said yesterday that blood screening was kept under constant review. "We have been screening for hepatitis B antigen for more than 20 years and that is believed to be perfectly adequate.
"The lifetime risk for HTLV-1 infection is 2 to 3 per cent and it is considered not worthwhile to screen donated blood."
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments